Luminex

New York University has been awarded

Life Technologies (Thermo Fisher Scientific) has been awarded

NEW YORK (GenomeWeb) – Luminex said after the close of the market on Monday that the US Food and Drug Administration has cleared three additional targets for its xTAG Gastrointestinal Pathogen Panel.

NEW YORK (GenomeWeb) – A Luminex-based SNP genotyping assay will serve as the main workhorse for a major new facility that intends to serve the US agricultural sector.

NEW YORK (GenomeWeb) – Two new papers have assessed the ability of Luminex's xTAG Gastrointestinal Pathogen Panel and competitive offerings to detect infectious pathogens.

Title: Assay plates, reader systems and methods for luminescence test measurements.
Patent Number: 8,808,627
Filed: Nov. 11, 2010

NEW YORK (GenomeWeb) — Luminex said today that the US Army Medical Research Institute of Infectious Diseases (USAMRIID) is using Luminex's xMAP technology to develop rapid diagnostics for the Ebola virus.

NEW YORK (GenomeWeb) – In July the stocks of companies operating in the omics research tools and molecular diagnostics spaces returned almost all of their gains from June as the

NEW YORK (GenomeWeb) – Demand for Luminex'sxTAG Gastrointestinal Pathogen Panel continues to increase despite the US Food and Drug Administration's recent clearance of a competitive assay sold by BioMérieux.

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its second-quarter revenues grew 2 percent year over year, driven by a jump in instrument sales.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.